1. Home
  2. HUM vs EW Comparison

HUM vs EW Comparison

Compare HUM & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Humana Inc.

HUM

Humana Inc.

HOLD

Current Price

$386.18

Market Cap

44.0B

Sector

Health Care

ML Signal

HOLD

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

HOLD

Current Price

$91.15

Market Cap

48.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUM
EW
Founded
1961
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.0B
48.9B
IPO Year
2002
1999

Fundamental Metrics

Financial Performance
Metric
HUM
EW
Price
$386.18
$91.15
Analyst Decision
Hold
Buy
Analyst Count
20
21
Target Price
$238.65
$96.37
AVG Volume (30 Days)
1.0M
4.3M
Earning Date
04-29-2026
04-23-2026
Dividend Yield
1.46%
N/A
EPS Growth
N/A
N/A
EPS
9.83
1.07
Revenue
$129,664,000,000.00
$6,067,600,000.00
Revenue This Year
$26.15
$13.39
Revenue Next Year
$6.07
$9.81
P/E Ratio
$39.10
$84.87
Revenue Growth
10.11
11.55
52 Week Low
$163.11
$72.30
52 Week High
$428.88
$96.29

Technical Indicators

Market Signals
Indicator
HUM
EW
Relative Strength Index (RSI) 53.61 56.52
Support Level $385.22 $81.19
Resistance Level $387.17 $93.91
Average True Range (ATR) 13.07 1.87
MACD 0.88 0.34
Stochastic Oscillator 81.11 67.95

Price Performance

Historical Comparison
HUM
EW

About HUM Humana Inc.

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: